ProQR Therapeutics N.V. Rightofuse Assets Increase Decrease In Revaluation Surplus
ProQR Therapeutics N.V. (PRQR) reported Rightofuse Assets Increase Decrease In Revaluation Surplus of EUR 415.00 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2022-04-29.
Discontinued › Notes
ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus · last filed 2022-04-29
| Period end | Rightofuse Assets Increase Decrease In Revaluation Surplus 12 month |
|---|---|
| 2021-12-31 | 415.00K EUR 20-F · filed 2022-04-29 |